AVITA Medical Book Value 2011-2026 | RCEL

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value AVITA Medical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-16.6 M	4.74 M	49.7 M	85.3 M	105 M	72.4 M	20.9 M	14 M	3.94 M	5.12 M	3.23 M	5.2 M	9.54 M	8.75 M	17.2 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
105 M	-16.6 M	25.9 M

Quarterly Book Value AVITA Medical

2025-Q3	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-6.67 M	-4.51 M	4.74 M	12.5 M	24.3 M	33.4 M	49.7 M	63.6 M	69.9 M	78.4 M	85.3 M	88.3 M	92.7 M	97.8 M	105 M	111 M	116 M	116 M	59.6 M	65.5 M	72.4 M	72.4 M	-	-	20.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
116 M	-6.67 M	62.1 M

Book Value of other stocks in the Medical devices industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
Medtronic PLC MDT	48.3 B	$ 86.75	0.2 %	$ 112 B	USA
BioSig Technologies BSGM	-1.42 M	-	37.08 %	$ 85.7 M	USA
GenMark Diagnostics, Inc. GNMK	196 M	-	-	$ 1.77 B	USA
Axonics Modulation Technologies AXNX	570 M	-	-	$ 3.31 B	USA
Lianluo Smart Limited LLIT	272 M	-	24.59 %	$ 44.8 M	China
Aziyo Biologics AZYO	27.7 M	-	1.37 %	$ 20.5 M	USA
Acutus Medical AFIB	-879 K	-	-26.83 %	$ 2.62 M	USA
Allied Healthcare Products AHPI	19.7 M	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	25.5 M	-	-5.86 %	$ 30.6 M	USA
Second Sight Medical Products EYES	17.6 M	-	-0.97 %	$ 54.4 M	USA
InspireMD NSPR	55.2 M	$ 1.75	-2.23 %	$ 113 M	Israel
Conformis CFMS	54.2 M	-	-	$ 16.4 M	USA
Orthofix Medical OFIX	450 M	$ 11.8	0.68 %	$ 467 M	Curacao
Cardiovascular Systems CSII	249 M	-	0.15 %	$ 844 M	USA
Inogen INGN	192 M	$ 6.39	1.11 %	$ 170 M	USA
Apollo Endosurgery APEN	32.6 M	-	-	$ 475 M	USA
Avinger AVGR	-6.2 M	-	-20.74 %	$ 369 K	USA
CryoLife, Inc. CRY	58.1 M	-	-4.14 %	$ 702 M	USA
Insulet Corporation PODD	1.52 B	$ 221.66	-1.71 %	$ 15.6 B	USA
CHF Solutions, Inc. CHFS	6.23 M	-	1.15 %	$ 34.5 M	USA
AxoGen AXGN	129 M	$ 33.48	2.67 %	$ 1.54 B	USA
Profound Medical Corp. PROF	31.2 M	$ 5.36	4.08 %	$ 180 M	Canada
CONMED Corporation CNMD	1.03 B	$ 36.6	0.04 %	$ 1.14 B	USA
Soliton, Inc. SOLY	243 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	2.61 B	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	229 M	-	0.03 %	$ 1.58 B	Israel
NanoVibronix NAOV	627 K	-	-	$ 1.08 M	USA
Electromed ELMD	43.2 M	$ 24.42	-1.13 %	$ 206 M	USA
Misonix, Inc. MSON	30.4 M	-	-	$ 462 M	USA
Neovasc NVCN	52.2 M	-	-	$ 111 M	Canada
MiMedx Group MDXG	257 M	$ 4.18	1.33 %	$ 618 M	USA
Intersect ENT, Inc. XENT	550 M	-	-	$ 955 M	USA
Cytosorbents Corporation CTSO	11.1 M	$ 0.68	-2.16 %	$ 37 M	USA
Aethlon Medical AEMD	5.12 M	$ 2.29	5.79 %	$ 3.57 M	USA
BIOLASE BIOL	1.96 M	-	-13.19 %	$ 166 K	USA
Sintx Technologies SINT	2.93 M	$ 2.61	1.62 %	$ 7.24 M	USA
AdaptHealth Corp. AHCO	1.53 B	$ 11.61	1.13 %	$ 1.57 B	USA
Myomo MYO	11.4 M	$ 0.71	2.39 %	$ 29.7 M	USA
Sensus Healthcare SRTS	48.1 M	$ 4.21	6.31 %	$ 68.7 M	USA
Nano-X Imaging Ltd. NNOX	189 M	$ 2.37	-1.29 %	$ 139 M	Israel
Penumbra PEN	1.43 B	$ 335.58	0.4 %	$ 13.1 B	USA
Invacare Corporation IVC	771 M	-	-	$ 24.7 M	USA
EDAP TMS S.A. EDAP	40.9 M	$ 3.7	-5.33 %	$ 138 M	France
Quanterix Corporation QTRX	296 M	$ 4.06	6.15 %	$ 173 M	USA
OrthoPediatrics Corp. KIDS	347 M	$ 16.14	1.45 %	$ 379 M	USA
Outset Medical OM	127 M	$ 3.54	0.28 %	$ 53.8 K	USA
Inspire Medical Systems INSP	781 M	$ 51.78	-0.58 %	$ 1.52 B	USA
Pulmonx Corporation LUNG	54.1 M	$ 1.33	1.15 %	$ 54.1 M	USA
Cutera CUTR	-172 M	-	-10.19 %	$ 1.99 M	USA